日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Updated Global Perspective of Atrial Fibrillation: Trends, Risk Factors, and Socioeconomic Disparities

心房颤动全球现状更新:趋势、风险因素和社会经济差异

Treewaree, Sukrit; Lip, Gregory Y H

Renal function decline in Asian patients with atrial fibrillation with warfarin and non-vitamin K antagonist oral anticoagulants: A report from the COOL-AF registry

亚洲房颤患者服用华法林和非维生素K拮抗剂口服抗凝剂后肾功能下降:来自COOL-AF注册研究的报告

Krittayaphong, Rungroj; Treewaree, Sukrit; Yindeengam, Ahthit; Lip, Gregory Y H

Discrepancies in Stroke Mortality Estimates: Kazakhstan's National Health Records and the Global Burden of Disease

中风死亡率估计值的差异:哈萨克斯坦国家健康记录与全球疾病负担

Treewaree, Sukrit; Pongjirapat, Natpatchara; Krittayaphong, Rungroj

Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry

心房颤动患者整体护理中“更佳护理路径”的组成部分:来自 COOL-AF 注册研究的成功率分析

Krittayaphong, Rungroj; Treewaree, Sukrit; Lip, Gregory Y H

Myocardial scar and left ventricular ejection fraction classification for electrocardiography image using multi-task deep learning

基于多任务深度学习的心电图图像心肌瘢痕和左心室射血分数分类

Boribalburephan, Atirut; Treewaree, Sukrit; Tantisiriwat, Noppawat; Yindeengam, Ahthit; Achakulvisut, Titipat; Krittayaphong, Rungroj

Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis

对于射血分数轻度降低或保留的心力衰竭患者,是否应该将钠-葡萄糖协同转运蛋白2抑制剂列为I类推荐药物?:一项更新的系统评价和荟萃分析

Treewaree, Sukrit; Kulthamrongsri, Narathorn; Owattanapanich, Weerapat; Krittayaphong, Rungroj